Success Metrics

Clinical Success Rate

60.0%

Based on 3 completed trials

Completion Rate

60%(3/5)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Terminated

2(40%)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

5(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(2)

Detailed Status

Completed3

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

60.0%

Most Advanced

Phase 1

Trials by Phase

Phase 15 (100.0%)

Trials by Status

terminated240%

completed360%

Recent Activity

0 active trials

Showing 5 of 5

terminatedphase_1

A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

NCT06662396

completedphase_1

A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

NCT06619665

Clinical Trials (5)

Showing 5 of 5 trials

NCT06179407Phase 1

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Terminated

NCT06567002Phase 1

A Study of MK-6552 and the Effect of Food in Healthy Participants (MK-6552-006)

Terminated

NCT06665230Phase 1

A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

Completed

NCT06662396Phase 1

A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

Completed

NCT06619665Phase 1

A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5